• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者口腔和肠道微生物组组成及其影响分析。

Analysis of Oral and Gut Microbiome Composition and Its Impact in Patients with Oral Squamous Cell Carcinoma.

机构信息

Department of Molecular Oral Medicine and Maxillofacial Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima 734-8553, Japan.

Department of Oral and Maxillofacial Surgery, Hiroshima University Hospital, Hiroshima 734-8553, Japan.

出版信息

Int J Mol Sci. 2024 May 31;25(11):6077. doi: 10.3390/ijms25116077.

DOI:10.3390/ijms25116077
PMID:38892262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11172797/
Abstract

The impact of gut and oral microbiota on the clinical outcomes of patients with oral squamous cell carcinoma (OSCC) is unknown. We compared the bacterial composition of dental plaque and feces between patients with OSCC and healthy controls (HCs). Fecal and dental plaque samples were collected from 7 HCs and 18 patients with OSCC before treatment initiation. Terminal restriction fragment-length polymorphism analysis of 16S rRNA genes was performed. Differences in bacterial diversity between the HC and OSCC groups were examined. We compared the occupancy of each bacterial species in samples taken from patients with OSCC and HCs and analyzed the correlation between PD-L1 expression in the tumor specimens and the occupancy of each bacterial species. The gut and oral microbiota of patients with OSCC were more varied than those of HCs. and were significantly more abundant in patients with OSCC than in HCs. The abundance of subcluster XIVa in the gut microbiota of the PD-L1-positive group was significantly greater than that in the PD-L1-negative group. The oral and gut microbiomes of patients with OSCC were in a state of dysbiosis. Our results suggest the possibility of new cancer therapies targeting these disease-specific microbiomes using probiotics and synbiotics.

摘要

口腔鳞状细胞癌(OSCC)患者的肠道和口腔微生物群对临床结局的影响尚不清楚。我们比较了 OSCC 患者和健康对照者(HCs)的牙菌斑和粪便中的细菌组成。在开始治疗前,从 7 名 HCs 和 18 名 OSCC 患者中收集粪便和牙菌斑样本。对 16S rRNA 基因进行末端限制性片段长度多态性分析。检查 HC 和 OSCC 组之间细菌多样性的差异。我们比较了来自 OSCC 患者和 HCs 的样本中每种细菌的定植情况,并分析了肿瘤标本中 PD-L1 表达与每种细菌定植之间的相关性。OSCC 患者的肠道和口腔微生物群比 HCs 的更具多样性。和在 OSCC 患者中明显比 HCs 更丰富。PD-L1 阳性组肠道微生物群中 XIVa 亚群的丰度明显高于 PD-L1 阴性组。OSCC 患者的口腔和肠道微生物群处于生态失调状态。我们的研究结果表明,使用益生菌和合生菌靶向这些疾病特异性微生物群的新癌症疗法具有可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/db7b36289308/ijms-25-06077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/2d7c0ab6a41e/ijms-25-06077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/3a5a5b2b0e02/ijms-25-06077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/eb854c73db0f/ijms-25-06077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/7a8445a63d57/ijms-25-06077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/db7b36289308/ijms-25-06077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/2d7c0ab6a41e/ijms-25-06077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/3a5a5b2b0e02/ijms-25-06077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/eb854c73db0f/ijms-25-06077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/7a8445a63d57/ijms-25-06077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac6/11172797/db7b36289308/ijms-25-06077-g005.jpg

相似文献

1
Analysis of Oral and Gut Microbiome Composition and Its Impact in Patients with Oral Squamous Cell Carcinoma.口腔鳞状细胞癌患者口腔和肠道微生物组组成及其影响分析。
Int J Mol Sci. 2024 May 31;25(11):6077. doi: 10.3390/ijms25116077.
2
16S rRNA based metagenomic analysis unveils unique oral microbial signatures in oral squamous cell carcinoma cases from Coastal Karnataka, India.基于 16S rRNA 的宏基因组分析揭示了印度喀拉拉邦沿海地区口腔鳞状细胞癌病例中独特的口腔微生物特征。
Acta Microbiol Immunol Hung. 2024 Jul 1;71(3):253-262. doi: 10.1556/030.2024.02307. Print 2024 Sep 18.
3
Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.唾液微生物组失调和细胞因子通过炎症影响口腔鳞状细胞癌。
Arch Microbiol. 2021 Jan;203(1):137-152. doi: 10.1007/s00203-020-02011-w. Epub 2020 Aug 11.
4
Inflammatory Bacteriome and Oral Squamous Cell Carcinoma.炎症细菌组与口腔鳞状细胞癌。
J Dent Res. 2018 Jun;97(6):725-732. doi: 10.1177/0022034518767118. Epub 2018 Apr 9.
5
Dysbiosis of the oral microbiota composition is associated with oral squamous cell carcinoma and the impact of radiotherapy: a pilot study.口腔微生物群落组成失调与口腔鳞状细胞癌及放疗的影响:一项初步研究。
FEMS Microbiol Lett. 2023 Jan 17;370. doi: 10.1093/femsle/fnad111.
6
Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer.口腔癌相关的口腔微生物组的组成和功能变化与基因突变有关。
Oral Oncol. 2018 Feb;77:1-8. doi: 10.1016/j.oraloncology.2017.12.005. Epub 2017 Dec 9.
7
The Oral Microbiota May Have Influence on Oral Cancer.口腔微生物群可能对口腔癌有影响。
Front Cell Infect Microbiol. 2020 Jan 15;9:476. doi: 10.3389/fcimb.2019.00476. eCollection 2019.
8
On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment.口腔潜在恶性和恶性疾病的口腔微生物群:生态失调、多样性丧失和病原体富集。
Int J Mol Sci. 2023 Feb 9;24(4):3466. doi: 10.3390/ijms24043466.
9
Salivary microbiome profiles of oral cancer patients analyzed before and after treatment.口腔癌患者治疗前后唾液微生物组谱分析。
Microbiome. 2023 Aug 5;11(1):171. doi: 10.1186/s40168-023-01613-y.
10
Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.PD-L2 表达在口腔鳞状细胞癌患者中的预后意义-与 PD-L1 表达谱的比较。
Cancer Med. 2019 Mar;8(3):1124-1134. doi: 10.1002/cam4.1929. Epub 2019 Jan 18.

引用本文的文献

1
Effect of Stimulated Salivary Volume on Dysbiosis of the Salivary Microbiome in Children and Young Adults.刺激唾液量对儿童和青年唾液微生物群失调的影响。
Int Dent J. 2025 Jun;75(3):1759-1770. doi: 10.1016/j.identj.2025.03.015. Epub 2025 Apr 8.

本文引用的文献

1
Mendelian randomization analysis to investigate the gut microbiome in oral and oropharyngeal cancer.孟德尔随机化分析探讨口腔和口咽癌中的肠道微生物组。
Front Cell Infect Microbiol. 2024 Jan 4;13:1210807. doi: 10.3389/fcimb.2023.1210807. eCollection 2023.
2
The Multi-dimensional Challenge of Poor Oral Health in Cirrhosis-Disparities and Solutions.肝硬化患者口腔健康状况不佳的多维度挑战——差异与解决方案
Gastroenterology. 2024 May;166(5):717-722. doi: 10.1053/j.gastro.2024.01.010. Epub 2024 Jan 13.
3
Oral microbiota in human health and disease: A perspective.
口腔微生物群在人类健康和疾病中的作用:一种观点。
Exp Biol Med (Maywood). 2023 Aug;248(15):1288-1301. doi: 10.1177/15353702231187645. Epub 2023 Sep 9.
4
Tumor-Infiltrating CD45RO Memory Cells Are Associated with Favorable Prognosis in Oral Squamous Cell Carcinoma Patients.肿瘤浸润性CD45RO记忆细胞与口腔鳞状细胞癌患者的良好预后相关。
Cancers (Basel). 2023 Apr 10;15(8):2221. doi: 10.3390/cancers15082221.
5
Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer.食管癌中肠道微生物具核梭杆菌与LINE-1甲基化水平之间的关系。
Esophagus. 2023 Oct;20(4):704-712. doi: 10.1007/s10388-023-01009-9. Epub 2023 May 12.
6
Oral Microflora in the Background of Oral Cancer: A Review.口腔癌背景下的口腔微生物群:综述
Cureus. 2022 Dec 30;14(12):e33129. doi: 10.7759/cureus.33129. eCollection 2022 Dec.
7
Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis.口腔微生物群在口腔肿瘤发生、肿瘤进展和转移中的作用。
Mol Oral Microbiol. 2023 Feb;38(1):9-22. doi: 10.1111/omi.12403. Epub 2022 Dec 10.
8
A longitudinal assessment of chronic periodontitis in Australian adults.澳大利亚成年人慢性牙周炎的纵向评估。
J Clin Periodontol. 2023 Feb;50(2):276-285. doi: 10.1111/jcpe.13741. Epub 2022 Nov 14.
9
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.粪便微生物群移植治疗首次或第二次艰难梭菌感染(EarlyFMT):一项随机、双盲、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1083-1091. doi: 10.1016/S2468-1253(22)00276-X. Epub 2022 Sep 22.
10
Colonic Delivery of Nutrients for Sustained and Prolonged Release of Gut Peptides: A Novel Strategy for Appetite Management.肠道内传递营养物质以实现肠道肽的持续和延长释放:一种用于管理食欲的新策略。
Mol Nutr Food Res. 2022 Oct;66(19):e2200192. doi: 10.1002/mnfr.202200192. Epub 2022 Aug 19.